APA (7th ed.) Citation

M, V., RR, P., JA, A., AM, C., VK, R., WK, K., . . . J, G. (2024). Author Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging. Neurology, 102(9), e209377. https://doi.org/10.1212/WNL.0000000000209377

Chicago Style (17th ed.) Citation

M, Vassilaki, et al. "Author Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging." Neurology 102, no. 9 (2024): e209377. https://doi.org/10.1212/WNL.0000000000209377.

MLA (9th ed.) Citation

M, Vassilaki, et al. "Author Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging." Neurology, vol. 102, no. 9, 2024, p. e209377, https://doi.org/10.1212/WNL.0000000000209377.